Annual Drug Patent Expirations for ELIGARD+KIT Eligard Kit is a drug marketed by Tolmar and is included in four NDAs. It is available from one supplier. There is one patent…
The post New patent expiration for Tolmar drug ELIGARD KIT appeared first on D…
New patent expiration for Tolmar drug ELIGARD KIT Read Post »
Annual Drug Patent Expirations for FENSOLVI+KIT Fensolvi Kit is a drug marketed by Tolmar and is included in one NDA. It is available from two suppliers. There is one patent…
The post New patent expiration for Tolmar drug FENSOLVI KIT appeared first on…
New patent expiration for Tolmar drug FENSOLVI KIT Read Post »
Annual Drug Patent Expirations for REVLIMID Revlimid is a drug marketed by Celgene and is included in one NDA. It is available from one supplier. There are fifteen patents protecting…
The post New patent expiration for Celgene drug REVLIMID appeared fi…
Annual Drug Patent Expirations for REBETOL Rebetol is a drug marketed by Merck Sharp Dohme and Schering and is included in two NDAs. There is one patent protecting this drug.…
The post New patent expiration for Schering drug REBETOL appeared first on D…
Annual Drug Patent Expirations for ONZETRA+XSAIL Onzetra Xsail is a drug marketed by Currax and is included in one NDA. It is available from one supplier. There are eighteen patents…
The post New patent expiration for Currax drug ONZETRA XSAIL appeared…
New patent expiration for Currax drug ONZETRA XSAIL Read Post »
Annual Drug Patent Expirations for LEVOXYL Levoxyl is a drug marketed by King Pharms and is included in one NDA. It is available from one supplier. There is one patent…
The post New patent expiration for King Pharms drug LEVOXYL appeared first on DrugP…
New patent expiration for King Pharms drug LEVOXYL Read Post »
NUZYRA (omadacycline tosylate) Paratek pharms inc Patent: 7,326,696 Expiration: Sep 24, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expirations…
Drug Patent Expirations for the Week of September 24, 2023 Read Post »
Annual Drug Patent Expirations for NUZYRA Nuzyra is a drug marketed by Paratek Pharms Inc and is included in two NDAs. It is available from one supplier. There are ten…
The post New patent expiration for Paratek Pharms drug NUZYRA appeared first on Dru…
New patent expiration for Paratek Pharms drug NUZYRA Read Post »
Annual Drug Patent Expirations for LAMICTAL+XR Lamictal Xr is a drug marketed by Glaxosmithkline Llc and is included in one NDA. It is available from one supplier. There are two…
The post New patent expiration for Glaxosmithkline Llc drug LAMICTAL XR a…
New patent expiration for Glaxosmithkline Llc drug LAMICTAL XR Read Post »
ACTOPLUS MET XR (metformin hydrochloride; pioglitazone hydrochloride) Takeda pharms usa Patent: 8,470,368 Expiration: Sep 19, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical…
The post Drug Patent Expiration…
Drug Patent Expirations for the Week of September 17, 2023 Read Post »